Bionano Genomics, Inc. (BNGO) is a genome analysis software solutions provider. The company offers Saphyr, a sample-to-result solution for structural variation analysis. BNGO offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions.
The company possesses technical potential. However, it still needs to bolster its consumables revenue through the growth of its installed machine base. In the third quarter, the company topped analysts’ revenue estimate of $6.79 million by 6.3%.
